Type II restriction modification system methylation subunit of Alicyclobacillus acidocaldarius

US9567595B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9567595-B2
Application numberUS-201514707231-A
CountryUS
Kind codeB2
Filing dateMay 8, 2015
Priority dateMay 5, 2010
Publication dateFeb 14, 2017
Grant dateFeb 14, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Isolated and/or purified polypeptides and nucleic acid sequences encoding polypeptides from Alicyclobacillus acidocaldarius are provided. Further provided are methods for modulating or altering recombination inside or outside of a cell using isolated and/or purified polypeptides and/or nucleic acid sequences from Alicyclobacillus acidocaldarius.

First claim

Opening claim text (preview).

What is claimed is: 1. A vector comprising a first nucleic acid sequence encoding a polypeptide having at least 90% sequence identity to SEQ ID No: 2891 and a second nucleic acid sequence heterologous to the first nucleic acid sequence. 2. The vector of claim 1 , wherein the polypeptide has activity at or below about pH 8. 3. The vector of claim 1 , wherein the polypeptide has activity at a temperature at or above about 50 degrees Celsius. 4. The vector of claim 1 , wherein the polypeptide has activity as a DNA adenine methylase. 5. A vector comprising a first nucleic acid sequence encoding the polypeptide of SEQ ID NO: 2891 and a second nucleic acid sequence heterologous to the first nucleic acid sequence. 6. The vector of claim 5 , wherein the first nucleic acid sequence comprises SEQ ID NO: 2892. 7. A method of modulating or altering nucleic acid methylation in a cell, the method comprising: providing the vector of claim 1 to a cell; and expressing the first nucleic acid sequence to produce the polypeptide. 8. The method according to claim 7 , wherein the modulation or alteration of nucleic acid methylation occurs at or below about pH 8. 9. The method according to claim 7 , wherein the modulation or alteration of nucleic acid methylation occurs at a temperature at or above about 50 degrees Celsius. 10. The method according to claim 7 , wherein the polypeptide is glycosylated, pegylated, or otherwise post-translationally modified. 11. The method according to claim 7 , wherein the polypeptide has activity as a DNA adenine methylase. 12. The method according to claim 7 , wherein the polypeptide has activity at or below about pH 8. 13. The method according to claim 7 , wherein the polypeptide has activity at a temperature at or above about 50 degrees Celsius. 14. A method of modulating or altering nucleic acid methylation, the method comprising: providing an isolated or purified polypeptide having at least 90% sequence identity to SEQ ID No: 2891 to a nucleotide sequence in which adenine demethylation is desired. 15. The method according to claim 14 , wherein the modulation or alteration of nucleic acid methylation occurs at or below about pH 8. 16. The method according to claim 14 , wherein the modulation or alteration of nucleic acid methylation occurs at a temperature at or above about 50 degrees Celsius. 17. The method according to claim 14 , wherein the purified or isolated polypeptide is glycosylated, pegylated, or otherwise post-translationally modified. 18. The method according to claim 14 , wherein the purified or isolated polypeptide has activity as a DNA adenine methylase. 19. The method according to claim 14 , wherein the purified or isolated polypeptide has activity at or below about pH 8. 20. The method according to claim 14 , wherein the purified or isolated polypeptide has activity at a temperature at or above about 50 degrees Celsius. 21. The vector of claim 5 , wherein the polypeptide has activity at or below about pH 8. 22. The vector of claim 5 , wherein the polypeptide has activity at a temperature at or above about 50 degrees Celsius. 23. The vector of claim 5 , wherein the polypeptide has activity as a DNA adenine methylase. 24. A vector comprising a first nucleic acid sequence encoding a polypeptide having at least 99% sequence identity to SEQ ID No: 2891 and a second nucleic acid sequence heterologous to the first nucleic acid sequence. 25. The vector of claim 24 , wherein the polypeptide has activity at or below about pH 8. 26. The vector of claim 24 , wherein the polypeptide has activity at a temperature at or above about 50 degrees Celsius. 27. The vector of claim 24 , wherein the polypeptide has activity as a DNA adenine methylase.

Assignees

Inventors

Classifications

  • C12N9/00Primary

    Enzymes; Proenzymes; Compositions thereof (preparations containing enzymes for cleaning teeth A61K8/66, A61Q11/00; medicinal preparations containing enzymes or proenzymes A61K38/43; enzyme containing detergent compositions C11D; {enzymes with nucleic acid structure, e.g. ribozymes, C12N15/113}); Processes for preparing, activating, inhibiting, separating or purifying enzymes (preparation of malt C12C1/00) · CPC title

  • derived from bacteria {or Archaea} · CPC title

  • Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation · CPC title

  • Methyltransferases (general) (2.1.1.) · CPC title

  • Site-specific DNA-methyltransferase (adenine-specific) (2.1.1.72) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9567595B2 cover?
Isolated and/or purified polypeptides and nucleic acid sequences encoding polypeptides from Alicyclobacillus acidocaldarius are provided. Further provided are methods for modulating or altering recombination inside or outside of a cell using isolated and/or purified polypeptides and/or nucleic acid sequences from Alicyclobacillus acidocaldarius.
Who is the assignee on this patent?
Battelle Energy Alliance Llc
What technology area does this patent fall under?
Primary CPC classification C12N9/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).